Medicare Enrolled
Dr. Uday Dandamudi, MD
Hematology · Trinity, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dandamudi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dandamudi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dandamudi
Dr. Uday Dandamudi is a hematology specialist in Trinity, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Dandamudi performed 74,813 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Dandamudi received a total of $98,868 from 92 pharmaceutical and/or device companies across 1317 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dandamudi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ 74,813 Medicare services
$98,868 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 113142 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗74,813
Medicare services
Bottom 45% in FL for hematology
Not available
Unique patients (not deduplicated)
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
46,410 | $0 | $4 |
| Anti-nausea injection (aprepitant) | 8,450 | $1 | $5 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
6,400 | $0 | $5 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
3,060 | $6 | $23 |
| Denosumab injection (Prolia/Xgeva) | 1,740 | $19 | $51 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,424 | $8 | $29 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,356 | $8 | $9 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,262 | $0 | $3 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,211 | $94 | $339 |
| Anti-nausea injection (Aloxi/palonosetron) | 910 | $1 | $28 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
430 | $10 | $69 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
286 | $12 | $61 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
276 | $96 | $378 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
171 | $5 | $20 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
168 | $1 | $6 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
112 | $45 | $189 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
111 | $93 | $285 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
104 | $28 | $156 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
90 | $59 | $239 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
75 | $21 | $84 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
73 | $9 | $42 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
72 | $2 | $7 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
64 | $22 | $79 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
64 | $1 | $3 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
60 | $62 | $197 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
59 | $3 | $11 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
56 | $15 | $56 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
56 | $135 | $556 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
50 | $49 | $178 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
44 | $25 | $89 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
43 | $110 | $453 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
39 | $23 | $156 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
28 | $16 | $59 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
22 | $2 | $8 |
| New patient office visit, complex (60-74 min) | 21 | $167 | $585 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
16 | $103 | $377 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
62.9% high complexity
30.8% medium
6.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$98,868
Total received (2018-2024)
Avg $14,124/year across 7 years
Top 4% in FL for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
92
Companies
1,317
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$13,213
2023
$12,441
2022
$16,029
2021
$3,531
2020
$5,263
2019
$5,759
2018
$42,633
Payments by company (2024)
Gilead Sciences, Inc.
$4,446
Exelixis Inc.
$3,197
AstraZeneca Pharmaceuticals LP
$1,717
BeiGene USA, Inc.
$675
E.R. Squibb & Sons, L.L.C.
$314
Novartis Pharmaceuticals Corporation
$304
Celgene Corporation
$270
SOBI, INC
$218
PFIZER INC.
$201
Janssen Biotech, Inc.
$177
Merck Sharp & Dohme LLC
$141
ABBVIE INC.
$125
Incyte Corporation
$121
ARRAY BIOPHARMA INC
$83
Astellas Pharma US Inc
$80
GlaxoSmithKline, LLC.
$80
Lilly USA, LLC
$70
GENZYME CORPORATION
$69
Takeda Pharmaceuticals U.S.A., Inc.
$69
Tempus AI, Inc
$67
Fennec Pharmaceuticals, Inc.
$65
TAIHO ONCOLOGY, INC.
$64
Regeneron Healthcare Solutions, Inc.
$62
Mirati Therapeutics, Inc.
$60
Alexion Pharmaceuticals, Inc.
$56
Pharmacosmos Therapeutics Inc.
$49
Daiichi Sankyo Inc.
$47
Stemline Therapeutics Inc.
$44
SERVIER PHARMACEUTICALS LLC
$43
Bayer Healthcare Pharmaceuticals Inc.
$41
Ipsen Biopharmaceuticals, Inc
$35
Eisai Inc.
$25
SpringWorks Therapeutics, Inc.
$25
Adaptive Biotechnologies Corporation
$24
PUMA BIOTECHNOLOGY, INC.
$23
Karyopharm Therapeutics Inc.
$22
Dendreon Pharmaceuticals LLC
$22
Myriad Genetic Laboratories, Inc.
$21
Agios Pharmaceuticals, Inc.
$21
Kite Pharma, Inc.
$20
JAZZ PHARMACEUTICALS INC.
$18
Top 3 companies account for 70.8% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$39,095
AstraZeneca Pharmaceuticals LP
$7,883
Incyte Corporation
$7,063
Gilead Sciences, Inc.
$4,822
Takeda Pharmaceuticals U.S.A., Inc.
$4,116
Exelixis Inc.
$3,759
Eisai Inc.
$3,693
Bayer HealthCare Pharmaceuticals Inc.
$3,670
Deciphera Pharmaceuticals Inc.
$3,481
Janssen Biotech, Inc.
$2,375
Novartis Pharmaceuticals Corporation
$1,754
Celgene Corporation
$1,436
CTI BioPharma Corp.
$1,266
EISAI INC.
$1,146
BeiGene USA, Inc.
$898
Genentech USA, Inc.
$858
PFIZER INC.
$844
Daiichi Sankyo Inc.
$812
GENZYME CORPORATION
$800
Janssen Scientific Affairs, LLC
$758
Amgen Inc.
$617
GlaxoSmithKline, LLC.
$616
Lilly USA, LLC
$542
Merck Sharp & Dohme Corporation
$483
Merck Sharp & Dohme LLC
$439
Seagen Inc.
$364
Alexion Pharmaceuticals, Inc.
$332
Kite Pharma, Inc.
$280
Myriad Genetic Laboratories, Inc.
$263
Regeneron Healthcare Solutions, Inc.
$226
SOBI, INC
$218
AbbVie Inc.
$212
Astellas Pharma US Inc
$210
Mirati Therapeutics, Inc.
$192
ABBVIE INC.
$188
Ipsen Biopharmaceuticals, Inc
$184
PUMA BIOTECHNOLOGY, INC.
$168
JAZZ PHARMACEUTICALS INC.
$162
EMD Serono, Inc.
$140
ARRAY BIOPHARMA INC
$139
Agios Pharmaceuticals, Inc.
$111
Bayer Healthcare Pharmaceuticals Inc.
$109
Seattle Genetics, Inc.
$98
Pharmacyclics LLC, An AbbVie Company
$97
TESARO, Inc.
$95
AbbVie, Inc.
$91
TAIHO ONCOLOGY, INC.
$79
Pharmacosmos Therapeutics Inc.
$76
MorphoSys, US Inc.
$75
PORTOLA PHARMACEUTICALS, INC.
$74
TerSera Therapeutics LLC
$73
Karyopharm Therapeutics Inc.
$70
SERVIER PHARMACEUTICALS LLC
$68
Tempus AI, Inc
$67
Janssen Products, LP
$65
Fennec Pharmaceuticals, Inc.
$65
Array BioPharma Inc.
$55
Boehringer Ingelheim Pharmaceuticals, Inc.
$52
Medtronic, Inc.
$51
Kyowa Kirin, Inc.
$48
Epizyme, Inc.,
$47
Stemline Therapeutics Inc.
$44
Jazz Pharmaceuticals Inc.
$42
Blueprint Medicines Corporation
$42
MEDIVATION FIELD SOLUTIONS LLC
$41
Puma Biotechnology, Inc.
$41
Foundation Medicine, Inc.
$38
GE HealthCare
$37
Dendreon Pharmaceuticals LLC
$36
AVEO Pharmaceuticals, Inc.
$35
Servier Pharmaceuticals LLC
$33
Clovis Oncology, Inc.
$30
Myovant Sciences Inc.
$30
Pharmacyclics LLC, an AbbVie Company
$26
Janssen Pharmaceuticals, Inc
$25
SpringWorks Therapeutics, Inc.
$25
Adaptive Biotechnologies Corporation
$24
CSL Behring
$20
Genmab U.S., Inc.
$20
Rigel Pharmaceuticals, Inc.
$19
ImmunoGen, Inc.
$18
Ethicon US, LLC
$18
Acrotech Biopharma Inc.
$18
G1 Therapeutics, Inc.
$17
Spectrum Pharmaceuticals Inc.
$17
Lantheus Medical Imaging, Inc.
$16
Apellis Pharmaceuticals, Inc.
$15
Aveo Pharmaceuticals, Inc.
$15
SANOFI-AVENTIS U.S. LLC
$14
Sumitomo Pharma America, Inc.
$14
Aurobindo Pharma USA, Inc.
$13
Acrotech Biopharma LLC
$12
Top 3 companies account for 54.7% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · ANORO · AUGTYRO · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BEVYXXA · BLENREP · BOSULIF · BRACANALYSIS CDX · BRAFTOVI · BRUKINSA · Bavencio · Braftovi · CABOMETYX · CALQUENCE · CARVYKTI · CERTUS 140 MICROWAVE ABLATION SYSTEM · CHANTIX · COSELA · CYMBALTA · CYRAMZA · Cabometyx · Cotellic · DARZALEX · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · EMPRINT · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EVENITY · EXKIVITY · Elahere · Empaveli · Enhertu · Epkinly · Erivedge · Erleada · FASLODEX · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GAUCHER-DISEASE · GAZYVA · GILOTRIF · Halaven · Herceptin · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INFLECTRA · INLYTA · INREBIC · Idelvion · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · MYRISK · Marqibo · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Padcev · Pedmark · Perjeta · Phesgo · Pomalyst · PreciseTumor · Prolia · QINLOCK · Quadramet · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · Rezlidhia · Rituxan Hycela · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SOLIRIS · SOMATULINE DEPOT · SUTENT · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TRELEGY ELLIPTA · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XERMELO · XGEVA · XPOVIO · XT CDX · XTANDI · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · Zevalin · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematologists in nearby ZIP areas
41
County median income
$67,384
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA TRINITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dandamudi is a mixed practice specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dandamudi experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Dandamudi performed 46,410 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Dandamudi receive payments from pharmaceutical companies?
Yes. Dr. Dandamudi received a total of $98,868 from 92 companies across 1,317 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dandamudi's costs compare to other hematologists in Trinity?
Dr. Dandamudi's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dandamudi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Trinity
Browse hematologists in Trinity ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology